Assistance Listing 93.395
Cancer Treatment Research
Follow the funding history and Grants.gov notices that share Assistance Listing 93.395.
Historical prime grant obligations
| Assistance Listing | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| 93.395 · Cancer Treatment Research | $1,122,545,111.30 | $1,135,508,818.10 | $1,255,868,696.31 |
Filter USAspending award search by Assistance Listing 93.395 to inspect individual awards.
Notices for this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-24-214 · National Institutes of Health · January 7, 2027 · 93.173, 93.233, 93.242, 93.273, 93.279, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.853, 93.865, 93.866, 93.867
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) PAR-25-079 · National Institutes of Health · January 7, 2027 · 93.394, 93.395
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) PAR-25-081 · National Institutes of Health · January 7, 2027 · 93.393, 93.394, 93.395, 93.399
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) RFA-CA-27-005 · National Institutes of Health · January 11, 2027 · 93.394, 93.395
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) PA-27-102 · National Institutes of Health · April 5, 2027 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) PA-27-100 · National Institutes of Health · April 5, 2027 · 93.068, 93.070, 93.073, 93.083, 93.084, 93.103, 93.113, 93.121, 93.136, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.326, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) PA-24-254 · National Institutes of Health · July 12, 2027 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.351, 93.352, 93.353, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional) PA-24-253 · National Institutes of Health · July 17, 2027 · 93.113, 93.121, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.351, 93.352, 93.353, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) PAR-24-325 · National Institutes of Health · September 7, 2027 · 93.286, 93.394, 93.395, 93.866, 93.867
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-25-080 · National Institutes of Health · September 7, 2027 · 93.113, 93.121, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.350, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.859, 93.866, 93.867, 93.879
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) RFA-CA-27-019 · National Institutes of Health · October 19, 2027 · 93.393, 93.394, 93.395, 93.396, 93.399
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-27-078 · National Institutes of Health · October 25, 2027 · 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.307, 93.361, 93.393, 93.394, 93.395, 93.399, 93.837, 93.838, 93.839, 93.840, 93.865, 93.866, 93.867
- Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed) PAR-25-336 · National Institutes of Health · November 15, 2027 · 93.395
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) PAR-25-134 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-25-148 · National Institutes of Health · January 7, 2028 · 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.865, 93.866, 93.867
- Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) PAR-25-338 · National Institutes of Health · January 7, 2028 · 93.121, 93.313, 93.394, 93.395, 93.867
- Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) PAR-25-337 · National Institutes of Health · January 7, 2028 · 93.394, 93.395
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) PAR-25-346 · National Institutes of Health · January 7, 2028 · 93.121, 93.393, 93.394, 93.395, 93.396, 93.399
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) PAR-25-321 · National Institutes of Health · January 7, 2028 · 93.393, 93.394, 93.395, 93.396, 93.399
- Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) PAR-25-175 · National Institutes of Health · January 7, 2028 · 93.393, 93.394, 93.395
- Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) PAR-24-311 · National Institutes of Health · January 7, 2028 · 93.394, 93.395, 93.396
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) PA-25-304 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.865, 93.866, 93.867, 93.879
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) PA-25-306 · National Institutes of Health · January 7, 2028 · 93.113, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.865, 93.866, 93.867, 93.879
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-25-301 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.143, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-25-298 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.866, 93.867
- INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required) RFA-OD-27-005 · National Institutes of Health · June 15, 2028 · 93.173, 93.233, 93.310, 93.350, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.865, 93.866
- INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed) RFA-OD-27-003 · National Institutes of Health · June 15, 2028 · 93.121, 93.173, 93.233, 93.310, 93.351, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.865, 93.866, 93.867, 93.879
- INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) RFA-OD-27-004 · National Institutes of Health · June 15, 2028 · 93.121, 93.173, 93.233, 93.242, 93.310, 93.350, 93.351, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.865, 93.866, 93.867, 93.879
- Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional) PAR-25-324 · National Institutes of Health · September 7, 2028 · 93.393, 93.394, 93.395, 93.396, 93.397, 93.399
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 · National Institutes of Health · November 30, 2028 · 93.113, 93.121, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.361, 93.372, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879, 93.989
- HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) RFA-NS-27-007 · National Institutes of Health · February 20, 2029 · 93.213, 93.233, 93.273, 93.279, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.865, 93.866, 93.867
- NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) PA-27-101 · National Institutes of Health · April 5, 2029 · 93.233, 93.242, 93.273, 93.307, 93.313, 93.350, 93.351, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) PAR-27-098 · National Institutes of Health · April 5, 2029 · 93.113, 93.121, 93.143, 93.172, 93.173, 93.233, 93.242, 93.273, 93.286, 93.307, 93.313, 93.350, 93.351, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867
- NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002 · National Institutes of Health · May 7, 2029 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.361, 93.372, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879, 93.989
- Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) PAR-28-090 · National Institutes of Health · May 25, 2029 · 93.121, 93.233, 93.242, 93.279, 93.307, 93.310, 93.361, 93.393, 93.394, 93.395, 93.396, 93.837, 93.838, 93.839, 93.840, 93.847, 93.855, 93.865, 93.866, 93.989
- NIH Research Program Projects (Parent P01 Clinical Trial Optional) PA-27-061 · National Institutes of Health · May 25, 2029 · 93.113, 93.172, 93.233, 93.273, 93.279, 93.307, 93.313, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.855, 93.866, 93.879
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-27-072 · National Institutes of Health · July 5, 2029 · 93.393, 93.394, 93.395, 93.396, 93.399, 93.853, 93.865, 93.867
- Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required) PAR-28-022 · National Institutes of Health · September 25, 2029 · 93.121, 93.395
Source scope
How the records were joined
Grants.gov postings were checked November 10, 2026. Notice details come from the official extract dated November 10, 2026 and the Grants.gov detail service where newer information was available. Deadline comparisons use the same opportunity ID, number and agency across notice versions. A revised date can reflect a new filing cycle. Read the current announcement and package for the deadline that applies to you.
USAspending history groups signed prime grant and cooperative-agreement obligations by exact Assistance Listing and fiscal year. Amendments can reduce a total. An obligation is a commitment. These figures cover the program’s reported transactions across awards and say nothing about available funds or the chance of an award under a particular notice. Missing program-year rows are shown as unavailable. Program figures should be read separately when a notice lists several programs.
This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services.
Grants.gov extracts · Treasury data guide · Treasury API · Download the America.co snapshot